Results 721-740 of 1,138,811 for in 'Dáil debates' OR (speaker:Tom Kitt OR speaker:Josepha Madigan OR speaker:Ruairi Ó Murchú OR speaker:Seán Canney OR speaker:John Lahart OR speaker:Marc Ó Cathasaigh OR speaker:Marc MacSharry OR speaker:Michael McGrath OR speaker:Ivana Bacik OR speaker:Cathal Crowe OR speaker:Michael Ring OR speaker:Seán Ó Fearghaíl OR speaker:Patricia Ryan OR speaker:Colm Brophy OR speaker:James Browne OR speaker:Holly Cairns OR speaker:Michael Creed OR speaker:David Cullinane OR speaker:Catherine Martin OR speaker:Donnchadh Ó Laoghaire OR speaker:Pa Daly OR speaker:Richard Boyd Barrett OR speaker:Mark Ward OR speaker:Bernard Durkan OR speaker:Paschal Donohoe OR speaker:Claire Kerrane OR speaker:Martin Heydon OR speaker:Róisín Shortall OR speaker:Norma Foley OR speaker:Aengus Ó Snodaigh OR speaker:Matt Carthy OR speaker:John Brady OR speaker:Gerald Nash OR speaker:Noel Grealish OR speaker:Richard O'Donoghue OR speaker:Louise O'Reilly OR speaker:Alan Farrell OR speaker:Pat Buckley OR speaker:Pádraig O'Sullivan OR speaker:Niamh Smyth) in 'Committee meetings'

Joint Oireachtas Committee on Jobs, Enterprise and Innovation: General Scheme of the Protection of Employees (Employers’ Insolvency) (Amendment) Bill 2024 (23 Oct 2024)

Louise O'Reilly: That is where my interest is, that is, whether they can do it without legal representation. Unfortunately and Ms Breathnach has seen this herself, where she or I might say that is handy enough, it is a form and we can log on and fly through it, I would not like to think any person might say to another - and we all know the incidents I am referring to - that they do not need to have legal...

Joint Oireachtas Committee on Jobs, Enterprise and Innovation: General Scheme of the Protection of Employees (Employers’ Insolvency) (Amendment) Bill 2024 (23 Oct 2024)

Louise O'Reilly: This covers holidays and any other incidentals that are-----

Joint Oireachtas Committee on Jobs, Enterprise and Innovation: General Scheme of the Protection of Employees (Employers’ Insolvency) (Amendment) Bill 2024 (23 Oct 2024)

Louise O'Reilly: Anything to do with pensions - and I have one, as we all do - gets very complicated. To go in to that for a moment as that is where I envisage a person might need some kind of representation or someone to help them, pensions are very complicated and it is easy to see the money when you get it but the operation of pension schemes can be extremely complex. I have a small concern where a...

Joint Oireachtas Committee on Jobs, Enterprise and Innovation: General Scheme of the Protection of Employees (Employers’ Insolvency) (Amendment) Bill 2024 (23 Oct 2024)

Louise O'Reilly: That is excellent, I thank Ms Breathnach. Part 4 of the historical employer deemed insolvent application will go all the way back to 1983. How many cases does Ms Breathnach think apply? It is possibly unknowable.

Joint Oireachtas Committee on Jobs, Enterprise and Innovation: General Scheme of the Protection of Employees (Employers’ Insolvency) (Amendment) Bill 2024 (23 Oct 2024)

Louise O'Reilly: I can appreciate that. In the event that there is an insolvency or deemed to be an insolvency and the employer is around but abroad, will it be necessary for the worker to make extensive efforts to contact them if they are in another jurisdiction? If they are simply not around, will this kick in?

Joint Oireachtas Committee on Jobs, Enterprise and Innovation: General Scheme of the Protection of Employees (Employers’ Insolvency) (Amendment) Bill 2024 (23 Oct 2024)

Louise O'Reilly: In the event that it happened that the person simply walked away and went to another jurisdiction, that would simply kick in? They do not have to come back or make contact or anything like that, they can be deemed as absent? Those are all of my questions. I apologise, I have to go, I am attending an event in Buswells Hotel. I thank the witnesses.

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: I welcome the witnesses and thank them for giving of their time so readily. How do we compare with the rest of Europe in terms of ability to detect, diagnose and treat? That is my first question. Who is the best in Europe? Who is the worst?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: For instance, whose services should we try to match in order to improve our standards? Who is the best out there, even with the limited information we have available? Who-----

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: How are patients identified? For example, can a patient living in Donegal, Kerry or the midlands rest assured that he or she will be detected on time and with sufficient scope for treatment and recovery?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: What is the best way to set about providing the data that would be helpful in dealing with this situation?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: Is that being set up at present? Can it be set up at present? Is it being encouraged? Is the ICS encouraging it or can it do so through the hospital system, GPs and so on?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: Is there a deficit in that area that is identifiable now, and within what timespan is it possible to address the issue?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: We need a strategy somewhat like the national cancer strategy of some years ago.

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: As regards women's health, Professor McKeown mentioned that this apparently applies throughout Europe as well in terms of danger of heart attacks, cardiovascular failure, etc. What is being done in Europe now to address that issue, and what is being done here?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: Professor McKeown mentioned a treatment that is restricted at the moment. Why is it restricted? What is it?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: Could we have a comparison done between the older drug and its effectiveness and the new drug, and could we avail of that for the committee, Chairman? I think it would be useful, and it could be used further. Is that possible?

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

Bernard Durkan: I have a very short time left. Obviously a strategy is required. Within that strategy certain items, such as the availability of particular drugs that are effective, need to identified. The thing that comes to mind also is there are a number of people who are in danger of heart failure but do not know it for some unknown reason, so the degree to which the services are available for...

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

David Cullinane: I welcome our witnesses and thank them for the extensive briefing documents they submitted, as well as the opening statement and the asks they have of this committee. I will start with the national strategy because it is important. The most important point the witnesses made in their presentation is we do not have an overarching national strategy and have not for five years. Just for the...

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

David Cullinane: I thank Professor McAdam. I see many of the critical issues the witnesses identified are issues common to a lot of areas we are hearing about. One is the lack of comprehensive national registries. That seems to be a problem across a whole range of diseases. Do the witnesses think there would be a step-change in that if we moved to electronic medical records and digitising the health...

Joint Oireachtas Committee on Health: Issues and Challenges relating to Cardiology: Irish Cardiac Society (23 Oct 2024)

David Cullinane: I thank Professor McAdam. I move to diagnostics, because it is one of those areas in healthcare where the National Treatment Purchase Fund does not publish the diagnostic waiting lists or indeed community waiting lists, which it should. Very often we have to keep digging and asking parliamentary questions to get some sense of how bad they are. We know that in some cases they are not great....